10. Lung Cancer Therapy Market - Geographical Analysis
10.1 North America Lung Cancer Therapy Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 North America Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 North America: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.1.3.1 North America: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.1.4 North America: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.1.5 North America: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.1.6 North America Lung Cancer Therapy Market, by Country
10.1.6.1 US
10.1.6.1.1 Overview
10.1.6.1.2 US Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.1.3 US: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.1.6.1.3.1 US: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.1.6.1.4 US: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.1.6.1.5 US: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.1.6.2 Canada
10.1.6.2.1 Overview
10.1.6.2.2 Canada Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.2.3 Canada: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.1.6.2.3.1 Canada: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.1.6.2.4 Canada: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.1.6.2.5 Canada: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.1.6.3 Mexico
10.1.6.3.1 Overview
10.1.6.3.2 Mexico Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.3.3 Mexico: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.1.6.3.3.1 Mexico: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.1.6.3.4 Mexico: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.1.6.3.5 Mexico: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.2 Europe Lung Cancer Therapy Market, Revenue and Forecast to 2030
10.2.1 Overview
10.2.2 Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Europe: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.2.3.1 Europe: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.2.4 Europe: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.2.5 Europe: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.2.6 Europe Lung Cancer Therapy Market, by Country
10.2.6.1 UK
10.2.6.1.1 Overview
10.2.6.1.2 UK Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.1.3 UK: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.2.6.1.3.1 UK: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.2.6.1.4 UK: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.2.6.1.5 UK: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.2.6.2 Germany
10.2.6.2.1 Overview
10.2.6.2.2 Germany Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.2.3 Germany: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.2.6.2.3.1 Germany: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.2.6.2.4 Germany: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.2.6.2.5 Germany: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.2.6.3 France
10.2.6.3.1 Overview
10.2.6.3.2 France Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.3.3 France: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.2.6.3.3.1 France: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.2.6.3.4 France: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.2.6.3.5 France: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.2.6.4 Italy
10.2.6.4.1 Overview
10.2.6.4.2 Italy Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.4.3 Italy: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.2.6.4.3.1 Italy: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.2.6.4.4 Italy: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.2.6.4.5 Italy: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.2.6.5 Spain
10.2.6.5.1 Overview
10.2.6.5.2 Spain Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.5.3 Spain: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.2.6.5.3.1 Spain: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.2.6.5.4 Spain: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.2.6.5.5 Spain: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.2.6.6 Russia
10.2.6.6.1 Overview
10.2.6.6.2 Russia Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.6.3 Russia: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.2.6.6.3.1 Russia: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.2.6.6.4 Russia: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.2.6.6.5 Russia: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.2.6.7 Rest of Europe
10.2.6.7.1 Overview
10.2.6.7.2 Rest of Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.7.3 Rest of Europe: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.2.6.7.3.1 Rest of Europe: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.2.6.7.4 Rest of Europe: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.2.6.7.5 Rest of Europe: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3 Asia Pacific Lung Cancer Therapy Market, Revenue and Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Asia Pacific: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.3.1 Asia Pacific: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.4 Asia Pacific: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.5 Asia Pacific: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6 Asia Pacific Lung Cancer Therapy Market, by Country
10.3.6.1 China
10.3.6.1.1 Overview
10.3.6.1.2 China Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.1.3 China: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.1.3.1 China: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.1.4 China: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.1.5 China: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.2 Japan
10.3.6.2.1 Overview
10.3.6.2.2 Japan Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.2.3 Japan: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.2.3.1 Japan: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.2.4 Japan: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.2.5 Japan: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.3 India
10.3.6.3.1 Overview
10.3.6.3.2 India Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.3.3 India: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.3.3.1 India: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.3.4 India: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.3.5 India: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.4 Australia
10.3.6.4.1 Overview
10.3.6.4.2 Australia Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.4.3 Australia: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.4.3.1 Australia: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.4.4 Australia: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.4.5 Australia: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.5 South Korea
10.3.6.5.1 Overview
10.3.6.5.2 South Korea Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.5.3 South Korea: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.5.3.1 South Korea: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.5.4 South Korea: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.5.5 South Korea: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.6 Southeast Asia
10.3.6.6.1 Overview
10.3.6.6.2 Southeast Asia Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.3 Southeast Asia: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.6.3.1 Southeast Asia: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.6.4 Southeast Asia: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.6.5 Southeast Asia: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.6.6 Singapore
10.3.6.6.6.1 Singapore Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.6.2 Singapore: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.6.6.2.1 Singapore: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.6.6.3 Singapore: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.6.6.4 Singapore: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.6.7 Malaysia
10.3.6.6.7.1 Malaysia Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.7.2 Malaysia: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.6.7.2.1 Malaysia: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.6.7.3 Malaysia: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.6.7.4 Malaysia: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.6.8 Indonesia
10.3.6.6.8.1 Indonesia Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.8.2 Indonesia: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.6.8.2.1 Indonesia: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.6.8.3 Indonesia: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.6.8.4 Indonesia: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.6.9 Vietnam
10.3.6.6.9.1 Vietnam Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.9.2 Vietnam: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.6.9.2.1 Vietnam: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.6.9.3 Vietnam: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.6.9.4 Vietnam: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.6.10 Cambodia
10.3.6.6.10.1 Cambodia Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.10.2 Cambodia: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.6.10.2.1 Cambodia: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.6.10.3 Cambodia: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.6.10.4 Cambodia: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.6.11 Philippines
10.3.6.6.11.1 Philippines Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.11.2 Philippines: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.6.11.2.1 Philippines: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.6.11.3 Philippines: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.6.11.4 Philippines: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.6.12 Rest of Southeast Asia
10.3.6.6.12.1 Rest of Southeast Asia Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.12.2 Rest of Southeast Asia: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.6.12.2.1 Rest of Southeast Asia: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.6.12.3 Rest of Southeast Asia: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.6.12.4 Rest of Southeast Asia: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.3.6.7 Rest of Asia Pacific
10.3.6.7.1 Overview
10.3.6.7.2 Rest of Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.7.3 Rest of Asia Pacific: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.3.6.7.3.1 Rest of Asia Pacific: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.3.6.7.4 Rest of Asia Pacific: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.3.6.7.5 Rest of Asia Pacific: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.4 Middle East & Africa Lung Cancer Therapy Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Middle East & Africa: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.4.3.1 Middle East & Africa: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.4.4 Middle East & Africa: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.4.5 Middle East & Africa: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.4.5.1 Middle East & Africa Lung Cancer Therapy Market, by Country
10.4.5.2 Saudi Arabia
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.4.5.2.3 Saudi Arabia: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.4.5.2.3.1 Saudi Arabia: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.4.5.2.4 Saudi Arabia: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.4.5.2.5 Saudi Arabia: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.4.5.3 South Africa
10.4.5.3.1 Overview
10.4.5.3.2 South Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.4.5.3.3 South Africa: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.4.5.3.3.1 South Africa: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.4.5.3.4 South Africa: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.4.5.3.5 South Africa: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.4.5.4 UAE
10.4.5.4.1 Overview
10.4.5.4.2 UAE Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.4.5.4.3 UAE: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.4.5.4.3.1 UAE: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.4.5.4.4 UAE: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.4.5.4.5 UAE: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.4.5.5 Rest of Middle East Africa
10.4.5.5.1 Overview
10.4.5.5.2 Rest of Middle East Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.4.5.5.3 Rest of Middle East Africa: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.4.5.5.3.1 Rest of Middle East Africa: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.4.5.5.4 Rest of Middle East Africa: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.4.5.5.5 Rest of Middle East Africa: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.5 South & Central America Lung Cancer Therapy Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 South & Central America: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.5.3.1 South & Central America: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.5.4 South & Central America: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.5.5 South & Central America: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.5.6 South & Central America Lung Cancer Therapy Market, by Country
10.5.6.1 Brazil
10.5.6.1.1 Overview
10.5.6.1.2 Brazil Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.1.3 Brazil: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.5.6.1.3.1 Brazil: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.5.6.1.4 Brazil: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.5.6.1.5 Brazil: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.5.6.2 Argentina
10.5.6.2.1 Overview
10.5.6.2.2 Argentina Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.2.3 Argentina: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.5.6.2.3.1 Argentina: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.5.6.2.4 Argentina: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.5.6.2.5 Argentina: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
10.5.6.3 Rest of South & Central America
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South & Central America Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.3.3 Rest of South & Central America: Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
10.5.6.3.3.1 Rest of South & Central America: Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)
10.5.6.3.5 Rest of South & Central America: Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)
List of Tables
Table 1. Lung Cancer Therapy Market Segmentation
Table 2. Global Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Lung Cancer Therapy Market, by Therapy Type- Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 7. US Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. US Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 9. US Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)
Table 10. US Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)
Table 18. Mexico Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 19. Europe Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 20. Europe Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 21. Europe Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 22. Europe Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. UK Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 24. UK Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 25. UK Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)
Table 26. UK Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 27. Germany Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 28. Germany Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 29. Germany Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)
Table 30. Germany Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 31. France Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 32. France Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 33. France Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)
Table 34. France Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 35. Italy Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 36. Italy Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 37. Italy Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)
Table 38. Italy Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 39. Spain Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 40. Spain Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 41. Spain Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)
Table 42. Spain Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 43. Russia Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 44. Russia Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 45. Russia Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)
Table 46. Russia Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 47. Rest of Europe Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 48. Rest of Europe Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)
Table 49. Rest of Europe Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)
Table 50. Rest of Europe Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 51. Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 52. Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 53. Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 54. Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 55. China Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 56. China Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 57. China Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 58. China Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 59. Japan Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 60. Japan Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 61. Japan Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 62. Japan Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 63. India Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 64. India Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 65. India Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 66. India Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 67. Australia Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 68. Australia Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 69. Australia Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 70. Australia Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 71. South Korea Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 72. South Korea Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 73. South Korea Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 74. South Korea Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 75. Southeast Asia Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 76. Southeast Asia Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 77. Southeast Asia Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 78. Southeast Asia Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 79. Singapore Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 80. Singapore Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 81. Singapore Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 82. Singapore Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 83. Malaysia Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 84. Malaysia Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 85. Malaysia Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 86. Malaysia Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 87. Indonesia Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 88. Indonesia Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 89. Indonesia Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 90. Indonesia Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 91. Vietnam Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 92. Vietnam Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 93. Vietnam Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 94. Vietnam Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 95. Cambodia Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 96. Cambodia Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 97. Cambodia Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 98. Cambodia Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 99. Philippines Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 100. Philippines Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 101. Philippines Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 102. Philippines Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 103. Rest of Southeast Asia Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 104. Rest of Southeast Asia Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 105. Rest of Southeast Asia Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of Southeast Asia Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 110. Rest of Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 111. Middle East & Africa Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 112. Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 113. Middle East & Africa Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 114. Middle East & Africa Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 115. Saudi Arabia Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 116. Saudi Arabia Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 117. Saudi Arabia Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 118. Saudi Arabia Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 119. South Africa Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 120. South Africa Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 121. South Africa Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 122. South Africa Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 123. UAE Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 124. UAE Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 125. UAE Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 126. UAE Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 127. Rest of Middle East Africa Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 128. Rest of Middle East Africa Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 129. Rest of Middle East Africa Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 130. Rest of Middle East Africa Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 131. South & Central America Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 132. South & Central America Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 133. South & Central America Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 134. South & Central America Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 135. Brazil Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 136. Brazil Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 137. Brazil Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 138. Brazil Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 139. Argentina Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 140. Argentina Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 141. Argentina Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 142. Argentina Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 143. Rest of South & Central America Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 144. Rest of South & Central America Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)
Table 145. Rest of South & Central America Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 146. Rest of South & Central America Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 147. Recent Inorganic Growth Strategies in the Lung Cancer Therapy Market
Table 148. Recent Organic Growth Strategies in Lung Cancer Therapy Market
Table 149. Glossary of Terms, Lung Cancer Therapy Market